Norovirus shedding among food and healthcare workers exposed to the virus in outbreak settings
Aurora Sabrià(Universitat de Barcelona), Susana Guix(Universitat de Barcelona), Ángela Domı́nguez(Instituto de Salud Carlos III), Rosa M Pintó(Universitat de Barcelona), Thais Cornejo(Vall d'Hebron Hospital Universitari), Albert Bosch(Department of Virology), Rosa Bartolomé(Universitat Autònoma de Barcelona), Núria Torner(Centro de Investigación Biomédica en Red), Mercedes de Simón(Agencia de Salud Pública de Barcelona), Ana Martı́nez(Consejo Superior de Investigaciones Científicas)
Cited by 56
Related Papers
COVID-19: Drug Targets and Potential Treatments
|Journal of Medicinal Chemistry|2020|469
First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease
|Journal of Medicinal Chemistry|2002|448
Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza
|Critical Care|2009|382
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
|Frontiers in Molecular Neuroscience|2011|348
Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
|Medicinal Research Reviews|2002|334